Seeing Is Believing

Currently out of the existing stock ratings of Bruce Nudell, 33 are a BUY (91.67%), 3 are a HOLD (8.33%).
Analyst Bruce Nudell, carries an average stock price target met ratio of 81.82% that have a potential upside of 22.07% achieved within 393 days. Previously, Bruce Nudell worked at TRUIST.
Bruce Nudell’s has documented 71 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABMD, ABIOMED at 14-May-2019.
Analyst best performing recommendations are on AXNX (AXONICS MODULATION TECHNOLOGIES).
The best stock recommendation documented was for EW (EDWARDS LIFESCIENCES CORP) at 8/10/2018. The price target of $56.67 was fulfilled within 47 days with a profit of $10.65 (23.14%) receiving and performance score of 4.92.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 29-Mar-2023
$21
$1.5 (7.69%)
$24
2 months 9 days ago
(31-Oct-2025)
7/8 (87.5%)
$2.53 (13.70%)
116
Hold
Since 12-Dec-2022
$21
$1.5 (7.69%)
$32
2 months 9 days ago
(31-Oct-2025)
6/18 (33.33%)
$2.53 (13.70%)
251
Hold
Since 31-Oct-2025
$22
$2.5 (12.82%)
$42
2 months 9 days ago
(31-Oct-2025)
1/4 (25%)
$3.53 (19.11%)
70
Buy
Since 02-Nov-2023
$31
$11.5 (58.97%)
$42
3 months 2 days ago
(07-Oct-2025)
6/13 (46.15%)
$8.1 (35.37%)
344
Hold
Since 04-Aug-2025
$25
$5.5 (28.21%)
$36
5 months 5 days ago
(04-Aug-2025)
1/11 (9.09%)
$2.72 (12.21%)
237
What Year was the first public recommendation made by Bruce Nudell?